{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:25:39Z","timestamp":1791296739008,"version":"4.1.0"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T00:00:00Z","timestamp":1314057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001297","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T20:40:14Z","timestamp":1314132014000},"page":"e1297","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":78,"title":["The Susceptibility of Trypanosomatid Pathogens to PI3\/mTOR Kinase Inhibitors Affords a New Opportunity for Drug Repurposing"],"prefix":"10.1371","volume":"5","author":[{"given":"Rosario","family":"Diaz-Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Matthew","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Galan-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Madeira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Saldivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin E.","family":"Karver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Beverley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Pollastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,23]]},"reference":[{"key":"ref1","article-title":"Human African trypanosomiasis: a guide for drug supply.","year":"2001","journal-title":"World Health Organization"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"F Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).","volume":"25","author":"JA Castro","year":"2006","journal-title":"Hum Exp Toxicol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pt.2008.04.006","article-title":"Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.","volume":"24","author":"HP de Koning","year":"2008","journal-title":"Trends Parasitol"},{"key":"ref5","first-page":"2240","article-title":"Mechanisms of resistance to antiparasitic agents.","volume":"2","author":"WE Secor","year":"2007","journal-title":"Man Clin Microbiol (9th Ed)"},{"key":"ref6","first-page":"1","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.","author":"SR Wilkinson","year":"2008","journal-title":"Proc Natl Acad Sci U S A, Early Ed"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases.","volume":"5","author":"S Nwaka","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.","volume":"464","author":"JA Frearson","year":"2010","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0020-7519(00)00043-6","article-title":"Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents.","volume":"30","author":"KT Andrews","year":"2000","journal-title":"International Journal for Parasitology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1074\/jbc.M413556200","article-title":"Resistance to a Protein Farnesyltransferase Inhibitor in Plasmodium falciparum.","volume":"280","author":"RT Eastman","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"ref11","article-title":"Target Repurposing for Neglected Diseases.","author":"RK Campbell","year":"2011","journal-title":"Future Medicinal Chemistry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome.","volume":"1","author":"AL Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1535-7163.MCT-08-0801","article-title":"Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy.","volume":"8","author":"NT Ihle","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref14","first-page":"1151","article-title":"PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies.","volume":"10","author":"SJ Harris","year":"2009","journal-title":"Curr Opin Invest Drugs (BioMed Cent)"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbapap.2007.10.003","article-title":"Targeting phosphoinositide 3-kinase\u2013Moving towards therapy.","volume":"1784","author":"R Marone","year":"2008","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.273.5272.239","article-title":"Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.","volume":"273","author":"J Choi","year":"1996","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1107\/S0907444998014747","article-title":"Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.","volume":"55","author":"J Liang","year":"1999","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/13543784.2010.499121","article-title":"New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.","volume":"19","author":"S Albert","year":"2010","journal-title":"Expert Opin Invest Drugs"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.","volume":"7","author":"ME Feldman","year":"2009","journal-title":"PLoS Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nchembio.117","article-title":"Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.","volume":"4","author":"B Apsel","year":"2008","journal-title":"Nat Chem Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1021\/jm900851f","article-title":"ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin: Design and Synthesis of Highly Potent and Selective Pyrazolopyrimidines.","volume":"52","author":"A Zask","year":"2009","journal-title":"J Med Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20090489","article-title":"Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).","volume":"421","author":"JM Garcia-Martinez","year":"2009","journal-title":"Biochem J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.bmcl.2009.08.038","article-title":"The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase.","volume":"19","author":"K Malagu","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0065-7743(09)04417-0","article-title":"Emerging therapies based on inhibitors of phosphatidyl-inositol-3-kinases.","volume":"44","author":"JM Nuss","year":"2009","journal-title":"Annu Rep Med Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition.","volume":"2","author":"DA Guertin","year":"2009","journal-title":"Sci Signal"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-7743(08)00012-2","article-title":"mTOR Inhibitors in Oncology.","volume":"43","author":"J Verheijen","year":"2008","journal-title":"Annu Rep Med Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbrc.2009.10.086","article-title":"The TryPIKinome of five human pathogenic trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum\u2013new tools for designing specific inhibitors.","volume":"390","author":"D Bahia","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2148-11-4","article-title":"Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery.","volume":"11","author":"JR Brown","journal-title":"BMC Evol Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"27600","DOI":"10.1074\/jbc.M602183200","article-title":"TbVps34, the trypanosome orthologue of Vps34, is required for Golgi complex segregation.","volume":"281","author":"BS Hall","year":"2006","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.1073\/pnas.0802668105","article-title":"Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation.","volume":"105","author":"A Barquilla","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1073\/pnas.1004599107","article-title":"Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity.","volume":"107","author":"L Madeira da Silva","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M110.120212","article-title":"Target of rapamycin (TOR)-like 1 kinase is involved in the control of polyphosphate levels and acidocalcisome maintenance in Trypanosoma brucei.","volume":"285","author":"TC de Jesus","year":"2010","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ceb.2009.01.024","article-title":"mTOR and the control of whole body metabolism.","volume":"21","author":"P Polak","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control.","volume":"10","author":"R Loewith","year":"2002","journal-title":"Molecular cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ceb.2009.08.007","article-title":"TOR signaling in invertebrates.","volume":"21","author":"A Soulard","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4161\/cc.8.5.7808","article-title":"Trypanosome TOR complex 2 functions in cytokinesis.","volume":"8","author":"A Barquilla","year":"2009","journal-title":"Cell Cycle"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.0901698106","article-title":"Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins.","volume":"106","author":"L Madeira da Silva","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S0031182004005906","article-title":"Human infectivity trait in Trypanosoma brucei: stability, heritability and relationship to sra expression.","volume":"129","author":"CM Turner","year":"2004","journal-title":"Parasitology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0001-706X(99)00080-7","article-title":"An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids.","volume":"74","author":"JD Onyango","year":"2000","journal-title":"Acta Trop"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro.","volume":"68","author":"B Raz","year":"1997","journal-title":"Acta Trop"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","article-title":"Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase.","volume":"40","author":"FS Buckner","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1128\/MCB.10.3.1084","article-title":"Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression.","volume":"10","author":"GM Kapler","year":"1990","journal-title":"Mol Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-6851(03)00142-7","article-title":"An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans.","volume":"130","author":"S Goyard","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.1169464","article-title":"Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector.","volume":"324","author":"NS Akopyants","year":"2009","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1073\/pnas.90.4.1599","article-title":"Plasticity in chromosome number and testing of essential genes in Leishmania by targeting.","volume":"90","author":"AK Cruz","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity.","volume":"7","author":"SM Maira","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref47","article-title":"In vivo imaging of transgenic Leishmania parasites in a live host.","author":"CJ Thalhofer","year":"2010","journal-title":"J Vis Exp"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation.","volume":"99","author":"GF Spath","year":"2001","journal-title":"Exp Parasitol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1158\/0008-5472.CAN-09-0299","article-title":"Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.","volume":"69","author":"K Yu","year":"2009","journal-title":"Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-07-0669","article-title":"A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.","volume":"68","author":"JR Garlich","year":"2008","journal-title":"Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1124\/jpet.105.083550","article-title":"LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.","volume":"314","author":"AS Kristof","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"11684","DOI":"10.1074\/jbc.270.19.11684","article-title":"Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils.","volume":"270","author":"J Ding","year":"1995","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1158\/0008-5472.CAN-07-2154","article-title":"A dual phosphoinositide-3-kinase alpha\/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma.","volume":"67","author":"QW Fan","year":"2007","journal-title":"Cancer Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","article-title":"A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma.","volume":"9","author":"QW Fan","year":"2006","journal-title":"Cancer Cell"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cell.2006.03.035","article-title":"A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.","volume":"125","author":"ZA Knight","year":"2006","journal-title":"Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"24463","DOI":"10.1074\/jbc.M704741200","article-title":"Inhibition of mammalian target of rapamycin signaling by 2-(morpholin-1-yl)pyrimido[2,1-alpha]isoquinolin-4-one.","volume":"282","author":"LM Ballou","year":"2007","journal-title":"J Biol Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1158\/0008-5472.CAN-08-4285","article-title":"Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235.","volume":"69","author":"DW McMillin","year":"2009","journal-title":"Cancer Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1158\/1535-7163.MCT-09-0160","article-title":"NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas.","volume":"8","author":"TJ Liu","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","article-title":"Targeting mammalian target of rapamycin (mTOR) for health and diseases.","volume":"12","author":"CK Tsang","year":"2007","journal-title":"Drug Discov Today"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.128.6.1163","article-title":"Microtubule polarity and dynamics in the control of organelle positioning, segregation, and cytokinesis in the trypanosome cell cycle.","volume":"128","author":"DR Robinson","year":"1995","journal-title":"J Cell Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/AAC.00225-09","article-title":"New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.","volume":"53","author":"T Wenzler","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref62","first-page":"1","article-title":"mTOR signaling pathway regulates the IL-12\/IL-10 axis in Leishmania donovani infection.","author":"S Cheekatla","year":"2011","journal-title":"Medical Microbiology and Immunology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jac\/dkq542","article-title":"In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani.","volume":"66","author":"K Seifert","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery.","volume":"110","author":"D-H Kim","year":"2002","journal-title":"Cell"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action.","volume":"110","author":"K Hara","year":"2002","journal-title":"Cell"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.","volume":"14","author":"DD Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.","volume":"6","author":"E Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.bmcl.2007.02.032","article-title":"Synthesis and biological evaluation of pyrido[3\u2032,2\u2032:4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors.","volume":"17","author":"M Hayakawa","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1002\/j.1460-2075.1996.tb00911.x","article-title":"Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.","volume":"15","author":"GJ Brunn","year":"1996","journal-title":"EMBO J"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).","volume":"269","author":"CJ Vlahos","year":"1994","journal-title":"J Biol Chem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1021\/jm049526a","article-title":"Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro.","volume":"48","author":"RJ Griffin","year":"2005","journal-title":"J Med Chem"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T14:39:13Z","timestamp":1638369553000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001297"}},"subtitle":[],"editor":[{"given":"Gary","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,23]]},"references-count":71,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001297","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,23]]}}}